Amrane, K., Hemon, P., Delarue, Y., Robert, C., Foulquier, N., Meur, C. L., Rochais, M. L., Marec, N., Pradier, O., Misery, L., Legoupil, D., Schalper, K. A., Uguen, A., Alemany, P., Massard, C., Berthou, C., Flippot, R., Italiano, A. (2026). Pretreatment spatial immune architecture and 1-year clinical benefit to first-line ICB in advanced melanoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.9539